TABLE 1.

Neutralizing and HI antibody titers of dengue virus-infected patients

Patient no.Age (yr)/sexabDisease daySerotypePRNT50cHI titerRatio of DEN/JE
DENbJEDENJENeutralizationHI
145/M5DEN180<10320d1,280d>81/4
229/M5DEN1160<1080d640d>161/8
15DEN12,56040>20,480d>20,480d641
322/M7DEN1160<1020d20d>161
44DEN11,024<1040d320d>1021/8
424/M4DEN1401010d40d41/4
9DEN110,240405,120d>20,480d256>1/4
557/M6DEN310401,280d10,240d1/41/8
19DEN310,2404010240d>20,480d256>1/2
625/M1DEN4<10<1020d20d11
18DEN4640402,560d10,240d41/4
730/M6DEN110<1020e10e>12
13DEN116010320e640e161/2
840/M7DEN1160401,280e2,560e41/2
13DEN1>64016010,240e>20,480e>4<1/2
958/M7DEN11010320e640e11/2
8DEN116040640e5,120e41/8
1035/F8DEN116010640e1,280e161/2
19DEN1>640402,560e5,120e>161/2
1142/M2DEN1<10<1010e<10e1>1
14DEN1160<101,280e2,560e>161/2
1254/M5DEN14010640e640e41
12DEN1>64040>20,480e>20,480e>161
1322/M5DEN1<10<1010e<10e1>1
9DEN14010320e320e41
1422/M4DEN1<1010320e40e<18
16DEN1>640405,120e>20,480e>16<1/4
1526/F8DEN140<10160e640e>41/4
23DEN1160<10320e160e>162
1626/F7DEN116010320e>20,480e16<1/64
16DEN1>64040>20,480e>20,480e>161
1727/M6DEN1<10<1040e<10e1>4
13DEN1640105,120e5,120e641
1827/F4DEN1101020e20e11
7DEN116010320e1,280e161/4
1925/F7DEN1101080e10e18
29DEN116010160e160e161
2030/F2DEN2160<1040e20e>162
9DEN22,560402,560e10,240e641/4
2134/F10DEN2160<10640e1,280e>161/2
14DEN2640<101,280e2,560e>641/2
2223/F5DEN24040160e1,280e11/8
9DEN2640401,280e5,120e161/4
236/F3DEN2<1016020e20e<1/161
19DEN26401602,560e10,240e41/4/PICK>
2424/F3DEN2<101080e40e<12
8DEN216040320e2,560e41/8
2536/M2DEN2<10<1080e40e12
6DEN2>6404010240e>20,480e>16<1/2
2629/M3DEN2<101020e20e<11
14DEN2160105,120e10,240e161/2
2722/F4DEN2<10<1040e<10e1>4
11DEN2160405,120e20,480e41/4
2826/M6DEN216040160e320e41/2
13DEN2>6404010,240e20,480e>161/2
2951/M4DEN2<10<1020e10e11
9DEN240<1040e10e>44
3014/M2DEN3<1016080e320e1/41/4
9DEN310,240640>20,480e>20,480e161
3133/F13DEN3160102,560e5,120e161/2
3221/F2DEN3<10<1010e10e11
9DEN31604010,240e>20,480e4<1/2
3337/M3DEN3<10<1040e10e14
9DEN3160102,560e5,120e161/2
3440/F2DEN3<10<1040e10e14
19DEN3160102,560e10,240e161/4
3530/M6DEN340<10160e20e>48
17DEN316010320e640e161/2
3625/F13DEN3160102,560e10,240e161/4
3721/F5DEN3<101040e40e<11
8DEN3160401,280e2,560e41/2
  • a M, male; F, female.

  • b Titer of antibody to infecting dengue virus serotype determined by neutralization assay.

  • c PRNT50, 50% plaque reduction neutralization titer.

  • d Antigen, DEN2 serotype.

  • e Antigen, DEN3 serotype.